The brominated flame retardants, PBDEs and HBCD, in Canadian human milk samples collected from 1992 to 2005; concentrations and trends

2014 ◽  
Vol 70 ◽  
pp. 1-8 ◽  
Author(s):  
John Jake Ryan ◽  
Dorothea F.K. Rawn



2011 ◽  
Vol 409 (19) ◽  
pp. 4048-4053 ◽  
Author(s):  
Per Ola Darnerud ◽  
Marie Aune ◽  
Lotta Larsson ◽  
Sanna Lignell ◽  
Tshinanne Mutshatshi ◽  
...  




2011 ◽  
Vol 111 (6) ◽  
pp. 737-743 ◽  
Author(s):  
Merete Eggesbø ◽  
Cathrine Thomsen ◽  
Jens V. Jørgensen ◽  
Georg Becher ◽  
Jon Øyvind Odland ◽  
...  


Author(s):  
qiqi li ◽  
Tao Wang ◽  
yuan zeng ◽  
yun fan ◽  
Shejun Chen ◽  
...  

The present study investigated legacy and novel brominated flame retardants (BFRs) in atmospheric PM2.5 associated with various urban source sectors in a city and electronic waste (e-waste) recycling facilities in...



2021 ◽  
Vol 102 ◽  
pp. 43-55
Author(s):  
Ceyhun Bereketoglu ◽  
Carina Modig ◽  
Ajay Pradhan ◽  
Patrik L. Andersson ◽  
Sotiria Stasinopoulou ◽  
...  


Vaccines ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 785
Author(s):  
Maurizio Guida ◽  
Daniela Terracciano ◽  
Michele Cennamo ◽  
Federica Aiello ◽  
Evelina La Civita ◽  
...  

Objective: The objective of this research is to demonstrate the release of SARS-CoV-2 Spike (S) antibodies in human milk samples obtained by patients who have been vaccinated with mRNABNT162b2 vaccine. Methods: Milk and serum samples were collected in 10 volunteers 20 days after the first dose and 7 seven days after the second dose of the mRNABNT162b2 vaccine. Anti-SARS-CoV-2 S antibodies were measured by the Elecsys® Anti-SARS-CoV-2 S ECLIA assay (Roche Diagnostics AG, Rotkreuz, Switzerland), a quantitative electrochemiluminescence immunometric method. Results: At first sample, anti-SARS-CoV-2 S antibodies were detected in all serum samples (103.9 ± 54.9 U/mL) and only in two (40%) milk samples with a low concentration (1.2 ± 0.3 U/mL). At the second sample, collected 7 days after the second dose, anti-SARS-CoV-2 S antibodies were detected in all serum samples (3875.7 ± 3504.6 UI/mL) and in all milk samples (41.5 ± 47.5 UI/mL). No correlation was found between the level of serum and milk antibodies; the milk antibodies/serum antibodies ratio was on average 2% (range: 0.2–8.4%). Conclusion: We demonstrated a release of anti-SARS-CoV-2 S antibodies in the breast milk of women vaccinated with mRNABNT162b2. Vaccinating breastfeeding women could be a strategy to protect their infants from COVID-19 infection.



Sign in / Sign up

Export Citation Format

Share Document